Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, ertugliflozin was noninferior to placebo with respect to major adverse cardiovascular events. (Fu...
Publications
3 shownHypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
OBJECTIVE To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diab...
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
In this meta-analysis, SGLT2 inhibitors were associated with a reduced risk of major adverse CV events; in addition, results suggest significant heterogeneity in associations wi...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 3,815
- Institution
- University of Tennessee Health Science Center
External Links
Identifiers
- ORCID
- 0000-0001-5318-9677
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.